Topics

Real-world data can help us better assess gaps in chronic #kidney disease patient care. Looking at early treatment experience and patterns, we can develop our therapies based on real-life settings to improve patient outcomes and alleviate economic burden.

11:00 EST 9 Nov 2019 | AztraZeneca

Real-world data can help us better assess gaps in chronic disease patient care. Looking at early treatment experience and patterns, we can develop our therapies based on real-life settings to improve patient outcomes and alleviate economic burden.

Original Article: Real-world data can help us better assess gaps in chronic #kidney disease patient care. Looking at early treatment experience and patterns, we can develop our therapies based on real-life settings to improve patient outcomes and alleviate economic burden.

NEXT ARTICLE

More From BioPortfolio on "Real-world data can help us better assess gaps in chronic #kidney disease patient care. Looking at early treatment experience and patterns, we can develop our therapies based on real-life settings to improve patient outcomes and alleviate economic burden."

Quick Search